SBTX
$4.53
Silverback Therapeutics
$.37
8.89%
SBTX
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.76)
Revenue:  $0.00 Mil
Wednesday
Feb 9
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SBTX reports earnings?
Beat
Meet
Miss

Where is SBTX's stock price going from here?
Up
Flat
Down
Stock chart of SBTX
Analysts
Summary of analysts' recommendations for SBTX
Score
Grade
Pivots
Resistance
$5.16
$4.87
$4.70

$4.40

Support
$4.24
$3.94
$3.77
Tweet
Growth
Description
Silverback Therapeutics Inc. is a clinical-stage biopharmaceutical company. Its ImmunoTAC technology platform, develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections and other serious diseases. Silverback Therapeutics Inc. is based in Seattle, United States.